Heritable diseases of the skeleton. Part I: Molecular insights into skeletal development‐transcription factors and signaling pathways1

S Mundlos, BR Olsen - The FASEB journal, 1997 - Wiley Online Library
S Mundlos, BR Olsen
The FASEB journal, 1997Wiley Online Library
The recent identification of the genetic basis of hereditary skeletal disorders is providing
important insights into the intricate processes of skeletal formation, growth, and
homeostasis. These processes include patterning events during condensation and
differentiation of mesenchymal cells to form cartilage precursors of the future bones, the
replacement of cartilage by bones through endochondral ossification, the growth of long
bones through proliferation and differentiation of chondrocytes in growth plates, and bone …
The recent identification of the genetic basis of hereditary skeletal disorders is providing important insights into the intricate processes of skeletal formation, growth, and homeostasis. These processes include patterning events during condensation and differentiation of mesenchymal cells to form cartilage precursors of the future bones, the replacement of cartilage by bones through endochondral ossification, the growth of long bones through proliferation and differentiation of chondrocytes in growth plates, and bone formation through differentiation of osteoblasts from mesenchymal cells in areas of intramembranous ossification. Defects in any of these processes can give rise to skeletal abnormalities. Mutations in transcription factors such as HOX and PAX and members of the transforming growth factor‐β superfamily cause disorders associated with abnormal mesenchymal con‐densation, whereas defects in the transcription factor SOX‐9 lead to abnormalities in chondrocyte differentiation. Abnormal growth plate function, resulting in dwarfism, is the consequence of mutations in receptors for fibroblast growth factors and parathyroid hormone‐related peptide. Premature closure of cranial sutures in intramembranous ossification is a feature of syndromes due to mutations in fibroblast growth factor receptors.—S. Mundlos, S., Olsen, B. R. Heritable diseases of the skeleton. Part I: Molecular insights into skeletal de‐velopment‐transcription factors and signaling pathways. FASEB J. 11, 125‐132 (1997)
Wiley Online Library